The Future of Reprocessed Used Medical Equipment

Global Medical Device Podcast · 11 Nov 2022 · 48m · Episode 289

What this episode covers

Scott Carson, founder of US Medical, Inc. and a key architect of the eBay Healthcare Marketplace, discusses the rapid acceleration of the secondary market for used medical devices, driven by the pandemic and recessionary pressures. He argues that manufacturers must shift from restricting resale to supporting the entire product lifecycle, including reprocessing and resale, to remain competitive. Carson highlights the current lack of regulatory oversight in unregulated marketplaces like eBay and Alibaba, advocating for 'trust enablers' such as certified reprocessing facilities and traceability systems to ensure patient safety and device performance.

Mentioned

Companies
US Medical, Inc., eBay, Alibaba, Greenlight Guru, Pfizer, Amgen, Ford, McKesson, Viking, Tesla, Apple

Other shows on the same ground, closest first.

  • Being an Engineer · 44m

    S1E35 Harley-Davidson, Device Reprocessing, & Keeping a High Level Perspective | Tim Rempfer

    Tim Rempfer, a senior engineer at Medline Renewal, discusses his career path from designing custom Harley-Davidson components at Sputhe Engineering to reprocessing one-time-use medical devices. He details the technical challenges of reverse-engineering OEM devices to meet FDA equivalence standards and the complexities of designing a new manufacturing facility. Rempfer emphasizes the importance of maintaining a high-level perspective to avoid tunnel vision and shares lessons on professional distance and knowing when to ask for help in high-stakes engineering environments.

  • The Amp Hour · 1h 03m

    Medical Kits, They're The Future

    Dave Jones and Chris Gammell discuss the shift to home-based electronics work during lockdown, highlighting Gammell's transition to lead-free soldering using GC10 paste and the resulting reflow profile challenges. They analyze the regulatory landscape for medical devices, noting that while current regulations are loosened for DIY kits, the industry remains heavily restricted by long product life cycles and code review standards. The conversation also covers the ease of sourcing custom cables via Alibaba, the failure of the Solace graphene heater due to glass shattering, and the vast complexity of power supply topologies like resonant mode and phase-shifted bridges.

  • The Amp Hour · 1h 29m

    Medical Electronics Education with Mark Palmeri

    Dr. Mark Palmeri, a professor at Duke University, discusses his BME Design Fellows program and the Tympanometer project, an open-source medical device built for low-resource communities. He explains how he uses open tools like KiCad, Zephyr RTOS, and Jupyter notebooks to teach practical engineering skills, emphasizing validation and verification (V&V) processes required for medical devices. Palmeri details the challenges of transitioning from academic prototyping to commercialization, including regulatory hurdles and the ethical considerations of cost-reduced medical hardware.

  • People of Packaging · 38m

    70 - Charlie Webb from Van Der Stahl Scientific

    Charlie Webb, president of Van Der Stahl Scientific, discusses the rigorous validation and regulatory requirements of medical device packaging, explaining why the process is often more complex than the device development itself. He highlights the critical role of sterile barrier systems in preventing healthcare-associated infections, noting that over 150,000 deaths occur annually in the US due to non-sterile devices. Webb also addresses the challenge of hospitals using inadequate, unvalidated sealing equipment due to budget constraints, advocating for the adoption of microprocessor-controlled systems that ensure reproducibility and reliability.

  • OnTrack · 45m

    Supply Chain Challenges in Medical Device Manufacturing

    Supply chain executive Simon Hinds discusses the unique complexities of medical device and life sciences supply chains, contrasting them with automotive and consumer electronics. He explains how regulatory barriers, traceability requirements like CFR 21 Part 11, and mutual recognition agreements impact sourcing and manufacturing strategies. Hinds details the challenges of scaling from prototype to volume, managing tier 1-3 supplier risks, and navigating geopolitical tariffs through diversification and postponement strategies.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.